MedTrace Logo

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

NCT06100016 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2024-02-07

No results posted yet for this study

Summary

The study is a real-world observational clinical study. Patients diagnosed as colorectal cancer through histopathology were screened and enrolled. Before anti-tumor treatment, colonoscopy biopsy tissue specimens, surgical specimens, and malignant pleural effusion or ascites specimens, etc. are collected. The investigators will perform a drug sensitivity testing based on a novel drug susceptibility testing method to test the commonly used anti-tumor treatment regimens. Patients were given conventional anti-tumor treatment according to the medical judgment of the doctors. Finally, the investigator will evaluate the consistency of clinical efficacy in colorectal cancer treatment and drug susceptibility outcomes.

Conditions

Sponsors & Collaborators

  • Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences

    collaborator UNKNOWN

  • Precedo Pharmaceuticals Co. Ltd.

    collaborator UNKNOWN

  • Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China

    collaborator UNKNOWN

  • Funan Liu

    lead OTHER

Principal Investigators

  • Zhenning Wang, doctor · The First Affiliated Hospital of China Medical Univeristy

  • Funan Liu, doctor · The First Affiliated Hospital of China Medical Univeristy

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-18
Primary Completion
2025-10-31
Completion
2025-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06100016 on ClinicalTrials.gov